AKT2
AKT2 (AKT serine/threonine kinase 2, also known as PKBβ) is a member of the AKT kinase family that phosphorylates several substrates and has been implicated in insulin signalling. It is a putative oncogene, formerly named v-akt murine thymoma viral oncogene homolog 2. Browse Assay Genie's current range of AKT2 research reagents below, or read on for the biology behind the target.
AKT2 is a serine/threonine-protein kinase that acts as a general protein kinase, phosphorylating a number of known proteins within signalling pathways. Several AKT2-specific substrates have been identified, including ANKRD2, C2CD5, CLK2 and PITX2. In insulin signalling, AKT2 regulates insulin-stimulated glucose transport by promoting translocation of the glucose transporter GLUT4 from intracellular stores to the plasma membrane. It does so by phosphorylating C2CD5 (CDP138) on Ser-197 in insulin-stimulated adipocytes. Through phosphorylation of CLK2 on Thr-343, AKT2 is also involved in insulin-regulated suppression of hepatic gluconeogenesis, and it may be a key regulator of glucose uptake.
AKT2 may also play a role in myoblast differentiation, possibly through phosphorylation of PITX2. Unphosphorylated PITX2 associates with an ELAVL1/HuR-containing complex that stabilises CCND1 (cyclin D1) mRNA and so supports cell proliferation. Phosphorylation by AKT2 impairs this association, destabilises CCND1 mRNA and favours progression towards differentiation. Under stress conditions, AKT2 is involved in the negative regulation of myogenesis by phosphorylating ANKRD2. The AKT2 protein is found in the cytoplasm, nucleus, cell membrane and early endosome.
The AKT2 gene encodes a protein of the protein kinase superfamily, in the AGC Ser/Thr protein kinase family and RAC subfamily, and is classed in the AKT kinase family and among pleckstrin homology domain containing genes. The NCBI Gene summary describes it as a putative oncogene whose overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. Orthologous genes are named Akt2 in both mouse and rat.
AKT2 drives insulin-stimulated GLUT4 translocation and contributes to suppression of hepatic gluconeogenesis, making it central to studies of glucose uptake.
AKT2 is a putative oncogene, and its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers.
AKT2 may influence myoblast differentiation through PITX2 phosphorylation and negatively regulates myogenesis under stress via ANKRD2.
AKT2 phosphorylates specific substrates including ANKRD2, C2CD5, CLK2 and PITX2, offering defined readouts for kinase signalling studies.
AKT2 is a serine/threonine kinase that phosphorylates substrates including ANKRD2, C2CD5, CLK2 and PITX2. It regulates insulin-stimulated glucose transport through GLUT4 translocation, is involved in suppression of hepatic gluconeogenesis, and may influence myoblast differentiation.
AKT2 is also called PKBβ, and its UniProt protein name is RAC-beta serine/threonine-protein kinase. The gene was previously named v-akt murine thymoma viral oncogene homolog 2. It belongs to the AKT kinase family and the RAC subfamily of AGC kinases.
The NCBI Gene summary describes AKT2 as a putative oncogene, with overexpression contributing to the malignant phenotype of some human ductal pancreatic cancers. Mouse and rat both carry an Akt2 ortholog; check the datasheet of any product for its validated reactivity.
Other AKT family members and AKT pathway partners with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P31751; product specifications from Assay Genie datasheets.